ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
REL
|
ENSG00000162924.9 | REL |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
REL | hg19_v2_chr2_+_61108650_61108687 | 0.18 | 5.1e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_58345569 | 4.07 |
ENST00000528954.1 ENST00000528489.1 |
LPXN |
leupaxin |
chr10_+_90750378 | 3.41 |
ENST00000355740.2 ENST00000352159.4 |
FAS |
Fas cell surface death receptor |
chr10_+_90750493 | 3.26 |
ENST00000357339.2 ENST00000355279.2 |
FAS |
Fas cell surface death receptor |
chr6_+_138188551 | 3.19 |
ENST00000237289.4 ENST00000433680.1 |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
chr6_+_29910301 | 2.43 |
ENST00000376809.5 ENST00000376802.2 |
HLA-A |
major histocompatibility complex, class I, A |
chr19_-_6591113 | 2.08 |
ENST00000423145.3 ENST00000245903.3 |
CD70 |
CD70 molecule |
chr7_+_69064300 | 1.85 |
ENST00000342771.4 |
AUTS2 |
autism susceptibility candidate 2 |
chr11_+_102188272 | 1.81 |
ENST00000532808.1 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr11_+_102188224 | 1.72 |
ENST00000263464.3 |
BIRC3 |
baculoviral IAP repeat containing 3 |
chr14_+_75988851 | 1.67 |
ENST00000555504.1 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr1_-_93426998 | 1.64 |
ENST00000370310.4 |
FAM69A |
family with sequence similarity 69, member A |
chr9_-_132805430 | 1.61 |
ENST00000446176.2 ENST00000355681.3 ENST00000420781.1 |
FNBP1 |
formin binding protein 1 |
chr9_-_117880477 | 1.61 |
ENST00000534839.1 ENST00000340094.3 ENST00000535648.1 ENST00000346706.3 ENST00000345230.3 ENST00000350763.4 |
TNC |
tenascin C |
chr5_-_149792295 | 1.56 |
ENST00000518797.1 ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74 |
CD74 molecule, major histocompatibility complex, class II invariant chain |
chr20_+_44746885 | 1.51 |
ENST00000372285.3 |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
chr18_+_21529811 | 1.50 |
ENST00000588004.1 |
LAMA3 |
laminin, alpha 3 |
chr5_+_49963239 | 1.48 |
ENST00000505554.1 |
PARP8 |
poly (ADP-ribose) polymerase family, member 8 |
chr8_-_119964434 | 1.45 |
ENST00000297350.4 |
TNFRSF11B |
tumor necrosis factor receptor superfamily, member 11b |
chr5_-_150460914 | 1.39 |
ENST00000389378.2 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr8_-_49834299 | 1.38 |
ENST00000396822.1 |
SNAI2 |
snail family zinc finger 2 |
chr18_+_21452804 | 1.35 |
ENST00000269217.6 |
LAMA3 |
laminin, alpha 3 |
chr18_+_21452964 | 1.32 |
ENST00000587184.1 |
LAMA3 |
laminin, alpha 3 |
chr6_+_32821924 | 1.31 |
ENST00000374859.2 ENST00000453265.2 |
PSMB9 |
proteasome (prosome, macropain) subunit, beta type, 9 |
chr4_+_169418195 | 1.30 |
ENST00000261509.6 ENST00000335742.7 |
PALLD |
palladin, cytoskeletal associated protein |
chr19_+_4229495 | 1.29 |
ENST00000221847.5 |
EBI3 |
Epstein-Barr virus induced 3 |
chr12_-_77272765 | 1.27 |
ENST00000547435.1 ENST00000552330.1 ENST00000546966.1 ENST00000311083.5 |
CSRP2 |
cysteine and glycine-rich protein 2 |
chr2_-_88355241 | 1.23 |
ENST00000347055.3 |
KRCC1 |
lysine-rich coiled-coil 1 |
chr12_-_49318715 | 1.23 |
ENST00000444214.2 |
FKBP11 |
FK506 binding protein 11, 19 kDa |
chr15_-_20193370 | 1.19 |
ENST00000558565.2 |
IGHV3OR15-7 |
immunoglobulin heavy variable 3/OR15-7 (pseudogene) |
chr2_-_191885686 | 1.19 |
ENST00000432058.1 |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
chr20_+_44746939 | 1.18 |
ENST00000372276.3 |
CD40 |
CD40 molecule, TNF receptor superfamily member 5 |
chr15_+_33010175 | 1.15 |
ENST00000300177.4 ENST00000560677.1 ENST00000560830.1 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
chr10_-_97050777 | 1.14 |
ENST00000329399.6 |
PDLIM1 |
PDZ and LIM domain 1 |
chr8_-_49833978 | 1.14 |
ENST00000020945.1 |
SNAI2 |
snail family zinc finger 2 |
chr9_-_136344197 | 1.10 |
ENST00000414172.1 ENST00000371897.4 |
SLC2A6 |
solute carrier family 2 (facilitated glucose transporter), member 6 |
chr5_-_150466692 | 1.08 |
ENST00000315050.7 ENST00000523338.1 ENST00000522100.1 |
TNIP1 |
TNFAIP3 interacting protein 1 |
chr10_+_13141585 | 1.06 |
ENST00000378764.2 |
OPTN |
optineurin |
chr17_-_7590745 | 1.05 |
ENST00000514944.1 ENST00000503591.1 ENST00000455263.2 ENST00000420246.2 ENST00000445888.2 ENST00000509690.1 ENST00000604348.1 ENST00000269305.4 |
TP53 |
tumor protein p53 |
chr15_+_85923797 | 1.04 |
ENST00000559362.1 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
chr12_+_7055631 | 1.03 |
ENST00000543115.1 ENST00000399448.1 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
chr12_+_53491220 | 1.02 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr4_+_169418255 | 1.02 |
ENST00000505667.1 ENST00000511948.1 |
PALLD |
palladin, cytoskeletal associated protein |
chr7_-_47579188 | 1.01 |
ENST00000398879.1 ENST00000355730.3 ENST00000442536.2 ENST00000458317.2 |
TNS3 |
tensin 3 |
chr18_+_33877654 | 1.00 |
ENST00000257209.4 ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3 |
formin homology 2 domain containing 3 |
chr8_+_123793633 | 0.99 |
ENST00000314393.4 |
ZHX2 |
zinc fingers and homeoboxes 2 |
chr3_-_178789993 | 0.97 |
ENST00000432729.1 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr3_+_57261743 | 0.96 |
ENST00000288266.3 |
APPL1 |
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 |
chr10_+_13142225 | 0.94 |
ENST00000378747.3 |
OPTN |
optineurin |
chr19_+_41725088 | 0.94 |
ENST00000301178.4 |
AXL |
AXL receptor tyrosine kinase |
chr5_+_82767284 | 0.93 |
ENST00000265077.3 |
VCAN |
versican |
chr10_+_13142075 | 0.91 |
ENST00000378757.2 ENST00000430081.1 ENST00000378752.3 ENST00000378748.3 |
OPTN |
optineurin |
chr14_+_75988768 | 0.91 |
ENST00000286639.6 |
BATF |
basic leucine zipper transcription factor, ATF-like |
chr19_-_50143452 | 0.88 |
ENST00000246792.3 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
chr1_-_209824643 | 0.88 |
ENST00000391911.1 ENST00000415782.1 |
LAMB3 |
laminin, beta 3 |
chr11_+_119039414 | 0.88 |
ENST00000409991.1 ENST00000292199.2 ENST00000409265.4 ENST00000409109.1 |
NLRX1 |
NLR family member X1 |
chr17_+_34640031 | 0.83 |
ENST00000339270.6 ENST00000482104.1 |
CCL4L2 |
chemokine (C-C motif) ligand 4-like 2 |
chr10_-_96122682 | 0.81 |
ENST00000371361.3 |
NOC3L |
nucleolar complex associated 3 homolog (S. cerevisiae) |
chr3_-_178790057 | 0.79 |
ENST00000311417.2 |
ZMAT3 |
zinc finger, matrin-type 3 |
chr2_-_113594279 | 0.78 |
ENST00000416750.1 ENST00000418817.1 ENST00000263341.2 |
IL1B |
interleukin 1, beta |
chr20_-_43977055 | 0.78 |
ENST00000372733.3 ENST00000537976.1 |
SDC4 |
syndecan 4 |
chr2_-_163175133 | 0.78 |
ENST00000421365.2 ENST00000263642.2 |
IFIH1 |
interferon induced with helicase C domain 1 |
chr17_+_34639793 | 0.76 |
ENST00000394465.2 ENST00000394463.2 ENST00000378342.4 |
CCL4L2 |
chemokine (C-C motif) ligand 4-like 2 |
chr12_-_76425368 | 0.72 |
ENST00000602540.1 |
PHLDA1 |
pleckstrin homology-like domain, family A, member 1 |
chr12_+_102271129 | 0.72 |
ENST00000258534.8 |
DRAM1 |
DNA-damage regulated autophagy modulator 1 |
chr10_+_89419370 | 0.71 |
ENST00000361175.4 ENST00000456849.1 |
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
chr11_+_7597639 | 0.70 |
ENST00000533792.1 |
PPFIBP2 |
PTPRF interacting protein, binding protein 2 (liprin beta 2) |
chr14_-_54955721 | 0.67 |
ENST00000554908.1 |
GMFB |
glia maturation factor, beta |
chr6_-_32821599 | 0.66 |
ENST00000354258.4 |
TAP1 |
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr2_+_238600933 | 0.65 |
ENST00000420665.1 ENST00000392000.4 |
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
chr10_+_104155450 | 0.63 |
ENST00000471698.1 ENST00000189444.6 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr19_+_2476116 | 0.63 |
ENST00000215631.4 ENST00000587345.1 |
GADD45B |
growth arrest and DNA-damage-inducible, beta |
chr15_+_85923856 | 0.61 |
ENST00000560302.1 ENST00000394518.2 ENST00000361243.2 ENST00000560256.1 |
AKAP13 |
A kinase (PRKA) anchor protein 13 |
chr10_+_30722866 | 0.60 |
ENST00000263056.1 |
MAP3K8 |
mitogen-activated protein kinase kinase kinase 8 |
chr6_-_31550192 | 0.60 |
ENST00000429299.2 ENST00000446745.2 |
LTB |
lymphotoxin beta (TNF superfamily, member 3) |
chr2_+_90077680 | 0.59 |
ENST00000390270.2 |
IGKV3D-20 |
immunoglobulin kappa variable 3D-20 |
chr22_-_39268308 | 0.59 |
ENST00000407418.3 |
CBX6 |
chromobox homolog 6 |
chr2_+_228189941 | 0.59 |
ENST00000353339.3 ENST00000354503.6 ENST00000530359.1 ENST00000531278.1 ENST00000409565.1 ENST00000452930.1 ENST00000409616.1 ENST00000337110.7 ENST00000525195.1 ENST00000534203.1 ENST00000524634.1 ENST00000349901.7 |
MFF |
mitochondrial fission factor |
chr22_-_39268192 | 0.58 |
ENST00000216083.6 |
CBX6 |
chromobox homolog 6 |
chr6_+_292051 | 0.58 |
ENST00000344450.5 |
DUSP22 |
dual specificity phosphatase 22 |
chr1_-_204380919 | 0.57 |
ENST00000367188.4 |
PPP1R15B |
protein phosphatase 1, regulatory subunit 15B |
chr2_+_131975882 | 0.56 |
ENST00000356920.5 ENST00000358087.5 |
POTEE |
POTE ankyrin domain family, member E |
chr2_+_204193149 | 0.55 |
ENST00000422511.2 |
ABI2 |
abl-interactor 2 |
chr8_-_101321584 | 0.54 |
ENST00000523167.1 |
RNF19A |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr6_-_29527702 | 0.54 |
ENST00000377050.4 |
UBD |
ubiquitin D |
chr2_+_204193101 | 0.53 |
ENST00000430418.1 ENST00000424558.1 ENST00000261016.6 |
ABI2 |
abl-interactor 2 |
chr16_+_50730910 | 0.53 |
ENST00000300589.2 |
NOD2 |
nucleotide-binding oligomerization domain containing 2 |
chr22_+_46067678 | 0.53 |
ENST00000381061.4 ENST00000252934.5 |
ATXN10 |
ataxin 10 |
chr15_+_71145578 | 0.53 |
ENST00000544974.2 ENST00000558546.1 |
LRRC49 |
leucine rich repeat containing 49 |
chr2_+_204193129 | 0.50 |
ENST00000417864.1 |
ABI2 |
abl-interactor 2 |
chr1_-_65432171 | 0.50 |
ENST00000342505.4 |
JAK1 |
Janus kinase 1 |
chr14_-_53417732 | 0.48 |
ENST00000399304.3 ENST00000395631.2 ENST00000341590.3 ENST00000343279.4 |
FERMT2 |
fermitin family member 2 |
chr20_-_44485835 | 0.48 |
ENST00000457981.1 ENST00000426915.1 ENST00000217455.4 |
ACOT8 |
acyl-CoA thioesterase 8 |
chr8_+_70404996 | 0.46 |
ENST00000402687.4 ENST00000419716.3 |
SULF1 |
sulfatase 1 |
chr15_+_67430339 | 0.45 |
ENST00000439724.3 |
SMAD3 |
SMAD family member 3 |
chr16_+_27325202 | 0.44 |
ENST00000395762.2 ENST00000562142.1 ENST00000561742.1 ENST00000543915.2 ENST00000449195.1 ENST00000380922.3 ENST00000563002.1 |
IL4R |
interleukin 4 receptor |
chr20_+_43803517 | 0.43 |
ENST00000243924.3 |
PI3 |
peptidase inhibitor 3, skin-derived |
chr19_-_41256207 | 0.41 |
ENST00000598485.2 ENST00000470681.1 ENST00000339153.3 ENST00000598729.1 |
C19orf54 |
chromosome 19 open reading frame 54 |
chr14_-_106610852 | 0.40 |
ENST00000390603.2 |
IGHV3-15 |
immunoglobulin heavy variable 3-15 |
chr4_+_26322185 | 0.40 |
ENST00000361572.6 |
RBPJ |
recombination signal binding protein for immunoglobulin kappa J region |
chr5_-_55290773 | 0.40 |
ENST00000502326.3 ENST00000381298.2 |
IL6ST |
interleukin 6 signal transducer (gp130, oncostatin M receptor) |
chr21_+_34775181 | 0.40 |
ENST00000290219.6 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr8_-_23712312 | 0.40 |
ENST00000290271.2 |
STC1 |
stanniocalcin 1 |
chr16_+_31044812 | 0.40 |
ENST00000313843.3 |
STX4 |
syntaxin 4 |
chr2_+_220094479 | 0.39 |
ENST00000323348.5 ENST00000453432.1 ENST00000409849.1 ENST00000416565.1 ENST00000410034.3 ENST00000447157.1 |
ANKZF1 |
ankyrin repeat and zinc finger domain containing 1 |
chr14_-_35873856 | 0.38 |
ENST00000553342.1 ENST00000216797.5 ENST00000557140.1 |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
chr19_-_51472031 | 0.36 |
ENST00000391808.1 |
KLK6 |
kallikrein-related peptidase 6 |
chr21_+_34775698 | 0.36 |
ENST00000381995.1 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr22_+_22712087 | 0.36 |
ENST00000390294.2 |
IGLV1-47 |
immunoglobulin lambda variable 1-47 |
chr12_+_56211703 | 0.36 |
ENST00000243045.5 ENST00000552672.1 ENST00000550836.1 |
ORMDL2 |
ORM1-like 2 (S. cerevisiae) |
chr12_-_9913489 | 0.35 |
ENST00000228434.3 ENST00000536709.1 |
CD69 |
CD69 molecule |
chr5_+_14143728 | 0.34 |
ENST00000344204.4 ENST00000537187.1 |
TRIO |
trio Rho guanine nucleotide exchange factor |
chr21_+_34775772 | 0.34 |
ENST00000405436.1 |
IFNGR2 |
interferon gamma receptor 2 (interferon gamma transducer 1) |
chr19_+_41725140 | 0.33 |
ENST00000359092.3 |
AXL |
AXL receptor tyrosine kinase |
chr16_-_15736953 | 0.33 |
ENST00000548025.1 ENST00000551742.1 ENST00000602337.1 ENST00000344181.3 ENST00000396368.3 |
KIAA0430 |
KIAA0430 |
chr16_-_15736881 | 0.32 |
ENST00000540441.2 |
KIAA0430 |
KIAA0430 |
chr17_-_8286484 | 0.32 |
ENST00000582556.1 ENST00000584164.1 ENST00000293842.5 ENST00000584343.1 ENST00000578812.1 ENST00000583011.1 |
RPL26 |
ribosomal protein L26 |
chr2_+_163175394 | 0.30 |
ENST00000446271.1 ENST00000429691.2 |
GCA |
grancalcin, EF-hand calcium binding protein |
chr15_+_22892663 | 0.30 |
ENST00000313077.7 ENST00000561274.1 ENST00000560848.1 |
CYFIP1 |
cytoplasmic FMR1 interacting protein 1 |
chr22_+_46546494 | 0.30 |
ENST00000396000.2 ENST00000262735.5 ENST00000420804.1 |
PPARA |
peroxisome proliferator-activated receptor alpha |
chr2_+_162016916 | 0.29 |
ENST00000405852.1 |
TANK |
TRAF family member-associated NFKB activator |
chr7_+_156742399 | 0.29 |
ENST00000275820.3 |
NOM1 |
nucleolar protein with MIF4G domain 1 |
chr1_+_16767195 | 0.28 |
ENST00000504551.2 ENST00000457722.2 ENST00000406746.1 ENST00000443980.2 |
NECAP2 |
NECAP endocytosis associated 2 |
chr11_+_10476851 | 0.28 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr20_-_36156293 | 0.28 |
ENST00000373537.2 ENST00000414542.2 |
BLCAP |
bladder cancer associated protein |
chr5_+_133984462 | 0.28 |
ENST00000398844.2 ENST00000322887.4 |
SEC24A |
SEC24 family member A |
chr16_-_122619 | 0.27 |
ENST00000262316.6 |
RHBDF1 |
rhomboid 5 homolog 1 (Drosophila) |
chr19_+_41256764 | 0.27 |
ENST00000243563.3 ENST00000601253.1 ENST00000597353.1 ENST00000599362.1 |
SNRPA |
small nuclear ribonucleoprotein polypeptide A |
chr2_+_204192942 | 0.27 |
ENST00000295851.5 ENST00000261017.5 |
ABI2 |
abl-interactor 2 |
chr3_+_183967409 | 0.26 |
ENST00000324557.4 ENST00000402825.3 |
ECE2 |
endothelin converting enzyme 2 |
chr21_+_34638656 | 0.26 |
ENST00000290200.2 |
IL10RB |
interleukin 10 receptor, beta |
chr13_-_38443860 | 0.26 |
ENST00000426868.2 ENST00000379681.3 ENST00000338947.5 ENST00000355779.2 ENST00000358477.2 ENST00000379673.2 |
TRPC4 |
transient receptor potential cation channel, subfamily C, member 4 |
chr10_+_17270214 | 0.25 |
ENST00000544301.1 |
VIM |
vimentin |
chr19_-_51471362 | 0.25 |
ENST00000376853.4 ENST00000424910.2 |
KLK6 |
kallikrein-related peptidase 6 |
chr3_+_197518100 | 0.24 |
ENST00000438796.2 ENST00000414675.2 ENST00000441090.2 ENST00000334859.4 ENST00000425562.2 |
LRCH3 |
leucine-rich repeats and calponin homology (CH) domain containing 3 |
chr1_-_113249948 | 0.24 |
ENST00000339083.7 ENST00000369642.3 |
RHOC |
ras homolog family member C |
chr19_-_4831701 | 0.23 |
ENST00000248244.5 |
TICAM1 |
toll-like receptor adaptor molecule 1 |
chr11_+_46299199 | 0.23 |
ENST00000529193.1 ENST00000288400.3 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
chrX_-_17878827 | 0.23 |
ENST00000360011.1 |
RAI2 |
retinoic acid induced 2 |
chr2_+_90153696 | 0.23 |
ENST00000417279.2 |
IGKV3D-15 |
immunoglobulin kappa variable 3D-15 (gene/pseudogene) |
chr5_+_150591678 | 0.22 |
ENST00000523466.1 |
GM2A |
GM2 ganglioside activator |
chr3_+_42201653 | 0.22 |
ENST00000341421.3 ENST00000396175.1 |
TRAK1 |
trafficking protein, kinesin binding 1 |
chr17_-_4852332 | 0.21 |
ENST00000572383.1 |
PFN1 |
profilin 1 |
chr4_-_185395672 | 0.21 |
ENST00000393593.3 |
IRF2 |
interferon regulatory factor 2 |
chr16_+_15737124 | 0.21 |
ENST00000396355.1 ENST00000396353.2 |
NDE1 |
nudE neurodevelopment protein 1 |
chr3_-_139108475 | 0.20 |
ENST00000515006.1 ENST00000513274.1 ENST00000514508.1 ENST00000507777.1 ENST00000512153.1 ENST00000333188.5 |
COPB2 |
coatomer protein complex, subunit beta 2 (beta prime) |
chr2_+_208394794 | 0.20 |
ENST00000536726.1 ENST00000374397.4 ENST00000452474.1 |
CREB1 |
cAMP responsive element binding protein 1 |
chr9_-_34637806 | 0.20 |
ENST00000477726.1 |
SIGMAR1 |
sigma non-opioid intracellular receptor 1 |
chr12_-_40013553 | 0.20 |
ENST00000308666.3 |
ABCD2 |
ATP-binding cassette, sub-family D (ALD), member 2 |
chr6_-_44233361 | 0.20 |
ENST00000275015.5 |
NFKBIE |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
chr16_+_53088885 | 0.20 |
ENST00000566029.1 ENST00000447540.1 |
CHD9 |
chromodomain helicase DNA binding protein 9 |
chr19_-_39390440 | 0.20 |
ENST00000249396.7 ENST00000414941.1 ENST00000392081.2 |
SIRT2 |
sirtuin 2 |
chr6_-_131384373 | 0.20 |
ENST00000392427.3 ENST00000525271.1 ENST00000527411.1 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
chr17_-_1420182 | 0.20 |
ENST00000421807.2 |
INPP5K |
inositol polyphosphate-5-phosphatase K |
chr19_+_14142535 | 0.19 |
ENST00000263379.2 |
IL27RA |
interleukin 27 receptor, alpha |
chr4_-_176733897 | 0.19 |
ENST00000393658.2 |
GPM6A |
glycoprotein M6A |
chr11_-_66313699 | 0.19 |
ENST00000526986.1 ENST00000310442.3 |
ZDHHC24 |
zinc finger, DHHC-type containing 24 |
chr10_+_104154229 | 0.19 |
ENST00000428099.1 ENST00000369966.3 |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
chr19_-_51471381 | 0.18 |
ENST00000594641.1 |
KLK6 |
kallikrein-related peptidase 6 |
chr3_+_179322573 | 0.18 |
ENST00000493866.1 ENST00000472629.1 ENST00000482604.1 |
NDUFB5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa |
chr2_-_89310012 | 0.18 |
ENST00000493819.1 |
IGKV1-9 |
immunoglobulin kappa variable 1-9 |
chr2_+_114647504 | 0.18 |
ENST00000263238.2 |
ACTR3 |
ARP3 actin-related protein 3 homolog (yeast) |
chr11_+_19798964 | 0.17 |
ENST00000527559.2 |
NAV2 |
neuron navigator 2 |
chr6_-_131384347 | 0.17 |
ENST00000530481.1 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
chr2_-_18741882 | 0.17 |
ENST00000381249.3 |
RDH14 |
retinol dehydrogenase 14 (all-trans/9-cis/11-cis) |
chr14_-_30396802 | 0.16 |
ENST00000415220.2 |
PRKD1 |
protein kinase D1 |
chr1_-_62190793 | 0.16 |
ENST00000371177.2 ENST00000606498.1 |
TM2D1 |
TM2 domain containing 1 |
chr4_+_114214125 | 0.16 |
ENST00000509550.1 |
ANK2 |
ankyrin 2, neuronal |
chr17_-_16118835 | 0.15 |
ENST00000582357.1 ENST00000436828.1 ENST00000411510.1 ENST00000268712.3 |
NCOR1 |
nuclear receptor corepressor 1 |
chr7_-_16844611 | 0.15 |
ENST00000401412.1 ENST00000419304.2 |
AGR2 |
anterior gradient 2 |
chr11_+_66406149 | 0.14 |
ENST00000578778.1 ENST00000483858.1 ENST00000398692.4 ENST00000510173.2 ENST00000506523.2 ENST00000530235.1 ENST00000532968.1 |
RBM4 |
RNA binding motif protein 4 |
chr12_-_56727676 | 0.14 |
ENST00000547572.1 ENST00000257931.5 ENST00000440411.3 |
PAN2 |
PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr9_-_115480303 | 0.13 |
ENST00000374234.1 ENST00000374238.1 ENST00000374236.1 ENST00000374242.4 |
INIP |
INTS3 and NABP interacting protein |
chr19_+_18794470 | 0.13 |
ENST00000321949.8 ENST00000338797.6 |
CRTC1 |
CREB regulated transcription coactivator 1 |
chr3_+_179322481 | 0.12 |
ENST00000259037.3 |
NDUFB5 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa |
chr15_-_89755034 | 0.12 |
ENST00000563254.1 |
RLBP1 |
retinaldehyde binding protein 1 |
chr6_+_152126790 | 0.12 |
ENST00000456483.2 |
ESR1 |
estrogen receptor 1 |
chr18_+_3252265 | 0.11 |
ENST00000580887.1 ENST00000536605.1 |
MYL12A |
myosin, light chain 12A, regulatory, non-sarcomeric |
chr1_-_159894319 | 0.11 |
ENST00000320307.4 |
TAGLN2 |
transgelin 2 |
chr20_-_36156125 | 0.11 |
ENST00000397135.1 ENST00000397137.1 |
BLCAP |
bladder cancer associated protein |
chr1_-_6453426 | 0.11 |
ENST00000545482.1 |
ACOT7 |
acyl-CoA thioesterase 7 |
chr8_+_39442097 | 0.10 |
ENST00000265707.5 ENST00000379866.1 ENST00000520772.1 ENST00000541111.1 |
ADAM18 |
ADAM metallopeptidase domain 18 |
chr19_-_39390350 | 0.10 |
ENST00000447739.1 ENST00000358931.5 ENST00000407552.1 |
SIRT2 |
sirtuin 2 |
chr16_+_84209539 | 0.10 |
ENST00000569735.1 |
DNAAF1 |
dynein, axonemal, assembly factor 1 |
chr9_+_101705893 | 0.10 |
ENST00000375001.3 |
COL15A1 |
collagen, type XV, alpha 1 |
chr14_-_30396948 | 0.10 |
ENST00000331968.5 |
PRKD1 |
protein kinase D1 |
chr11_+_19799327 | 0.09 |
ENST00000540292.1 |
NAV2 |
neuron navigator 2 |
chr17_+_26662730 | 0.09 |
ENST00000226225.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr16_-_75498553 | 0.08 |
ENST00000569276.1 ENST00000357613.4 ENST00000561878.1 ENST00000566980.1 ENST00000567194.1 |
TMEM170A RP11-77K12.1 |
transmembrane protein 170A Uncharacterized protein |
chr22_-_46659219 | 0.08 |
ENST00000253255.5 |
PKDREJ |
polycystin (PKD) family receptor for egg jelly |
chr6_-_131291572 | 0.08 |
ENST00000529208.1 |
EPB41L2 |
erythrocyte membrane protein band 4.1-like 2 |
chr6_-_46048116 | 0.08 |
ENST00000185206.6 |
CLIC5 |
chloride intracellular channel 5 |
chr10_+_49514698 | 0.07 |
ENST00000432379.1 ENST00000429041.1 ENST00000374189.1 |
MAPK8 |
mitogen-activated protein kinase 8 |
chr17_-_1420006 | 0.06 |
ENST00000320345.6 ENST00000406424.4 |
INPP5K |
inositol polyphosphate-5-phosphatase K |
chr7_-_98741714 | 0.06 |
ENST00000361125.1 |
SMURF1 |
SMAD specific E3 ubiquitin protein ligase 1 |
chr2_+_162016827 | 0.06 |
ENST00000429217.1 ENST00000406287.1 ENST00000402568.1 |
TANK |
TRAF family member-associated NFKB activator |
chr16_+_67282853 | 0.06 |
ENST00000299798.11 |
SLC9A5 |
solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 |
chr3_+_89156674 | 0.06 |
ENST00000336596.2 |
EPHA3 |
EPH receptor A3 |
chr11_-_61734599 | 0.06 |
ENST00000532601.1 |
FTH1 |
ferritin, heavy polypeptide 1 |
chr9_+_130547958 | 0.06 |
ENST00000421939.1 ENST00000373265.2 |
CDK9 |
cyclin-dependent kinase 9 |
chr22_-_43036607 | 0.06 |
ENST00000505920.1 |
ATP5L2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.7 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.4 | 21.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.4 | 8.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.3 | 3.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 6.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 2.6 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.1 | 5.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 2.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 3.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 2.4 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 3.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.4 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.1 | 4.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 1.2 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.9 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 5.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 3.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 2.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 1.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 2.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.8 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.7 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.9 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.5 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 0.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.6 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 2.7 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 2.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 2.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 2.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 4.8 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 1.8 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.4 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 1.5 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.1 | 2.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 4.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 1.3 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 2.2 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.0 | 0.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 4.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 1.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.0 | 0.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.7 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 1.5 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 1.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 1.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.0 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 1.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 1.2 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.6 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 0.9 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 1.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.2 | 4.0 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 3.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 1.3 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.2 | 1.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.8 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.0 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.1 | 4.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.1 | 0.8 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 0.3 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.7 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.3 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 0.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 4.0 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.0 | 0.6 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.0 | 0.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0016938 | kinesin I complex(GO:0016938) |
0.0 | 1.2 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.0 | 0.4 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.2 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 5.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.3 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 1.8 | GO:0002102 | podosome(GO:0002102) |
0.0 | 1.1 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 1.6 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 0.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.0 | 6.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.7 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 3.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
0.0 | 0.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 1.8 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.0 | 0.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.0 | 0.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.0 | 0.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.0 | 1.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.4 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.0 | 0.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.9 | GO:1904724 | specific granule lumen(GO:0035580) tertiary granule lumen(GO:1904724) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.0 | 0.4 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.5 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 1.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 3.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.3 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 4.0 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 1.5 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 4.3 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 1.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.0 | 3.4 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 2.1 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 1.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 1.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.0 | 1.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.5 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.7 | 2.8 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.6 | 1.9 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 2.2 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.5 | 1.4 | GO:0031394 | positive regulation of prostaglandin biosynthetic process(GO:0031394) positive regulation of unsaturated fatty acid biosynthetic process(GO:2001280) |
0.4 | 3.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.3 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 1.7 | GO:0021564 | vagus nerve development(GO:0021564) |
0.4 | 0.4 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
0.4 | 1.5 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.4 | 4.2 | GO:0009414 | response to water deprivation(GO:0009414) |
0.4 | 1.9 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.4 | 2.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.4 | 3.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.3 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 1.2 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.3 | 0.8 | GO:0034146 | B-1 B cell homeostasis(GO:0001922) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 0.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.2 | 2.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 0.5 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
0.2 | 1.7 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.2 | 0.6 | GO:2000697 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.2 | 1.4 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.2 | 0.5 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.2 | 1.7 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 0.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 1.1 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 3.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:2000777 | positive regulation of oocyte maturation(GO:1900195) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.5 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of type B pancreatic cell development(GO:2000078) |
0.1 | 0.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.1 | 0.7 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.6 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) positive regulation of hyaluronan biosynthetic process(GO:1900127) |
0.1 | 0.3 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.1 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.1 | 0.3 | GO:0031346 | positive regulation of cell projection organization(GO:0031346) |
0.1 | 0.2 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 1.7 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.1 | 0.7 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.9 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.3 | GO:1904457 | beta-glucoside metabolic process(GO:1901804) beta-glucoside catabolic process(GO:1901805) positive regulation of neuronal action potential(GO:1904457) |
0.1 | 0.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.3 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.3 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
0.1 | 0.3 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 1.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.4 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.1 | 2.0 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 4.0 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.9 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.2 | GO:0007497 | posterior midgut development(GO:0007497) endothelin receptor signaling pathway(GO:0086100) |
0.1 | 0.2 | GO:0002384 | hepatic immune response(GO:0002384) response to prolactin(GO:1990637) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
0.1 | 1.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 1.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 1.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.0 | 1.3 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.0 | 0.2 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.4 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.0 | GO:0050713 | regulation of interleukin-1 beta secretion(GO:0050706) negative regulation of interleukin-1 beta secretion(GO:0050713) |
0.0 | 0.2 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.0 | 0.8 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.8 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.1 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.0 | 0.7 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 0.5 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.3 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.0 | 0.6 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.0 | 0.8 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.8 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.1 | GO:0030166 | proteoglycan biosynthetic process(GO:0030166) |
0.0 | 2.8 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.0 | 0.9 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.3 | GO:0043584 | nose development(GO:0043584) |
0.0 | 0.2 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.3 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.0 | 0.5 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.1 | GO:0035973 | aggrephagy(GO:0035973) |
0.0 | 0.3 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.6 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.0 | 0.1 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) inositol phosphate catabolic process(GO:0071545) |
0.0 | 0.9 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.0 | 0.6 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.3 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.4 | GO:0042127 | regulation of cell proliferation(GO:0042127) |
0.0 | 0.1 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.0 | 0.1 | GO:2000360 | positive regulation of female gonad development(GO:2000196) regulation of ovarian follicle development(GO:2000354) negative regulation of binding of sperm to zona pellucida(GO:2000360) |
0.0 | 3.0 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.2 | GO:1900103 | positive regulation of endoplasmic reticulum unfolded protein response(GO:1900103) |
0.0 | 0.7 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 0.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.0 | 1.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.0 | 0.1 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.0 | 0.2 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.0 | 0.5 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.0 | 0.0 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 1.3 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.4 | 2.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.4 | 1.4 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) arachidonate 15-lipoxygenase activity(GO:0050473) |
0.3 | 1.6 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.3 | 6.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.3 | 1.5 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 3.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.2 | 1.6 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.2 | 2.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.2 | 2.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.5 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 2.0 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.8 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 0.4 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 1.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 3.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 1.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.7 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.3 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.3 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.1 | 0.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.3 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.1 | 1.9 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 1.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.1 | 1.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 0.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.0 | 4.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.7 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.5 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.0 | 0.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 1.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 1.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.1 | GO:0016972 | flavin-linked sulfhydryl oxidase activity(GO:0016971) thiol oxidase activity(GO:0016972) |
0.0 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.0 | 3.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.7 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.7 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.9 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.0 | 0.2 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.9 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.0 | 0.6 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.5 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.0 | 3.5 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.5 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.0 | 1.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.0 | 0.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0031435 | MAP kinase kinase kinase kinase activity(GO:0008349) mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.0 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 5.9 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.0 | 4.1 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.9 | 9.4 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.9 | 11.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.8 | 4.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.7 | 4.0 | GO:0046979 | TAP2 binding(GO:0046979) |
0.6 | 3.2 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.3 | 3.6 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
0.3 | 13.7 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 3.2 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 10.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 1.7 | GO:0019863 | IgE binding(GO:0019863) |
0.2 | 1.5 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.2 | 0.5 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 1.4 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 1.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 2.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.1 | 1.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 1.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 5.5 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 2.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.8 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 3.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 2.9 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.1 | 3.9 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.1 | 1.8 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.1 | 2.0 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.7 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.1 | 2.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.9 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 2.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.9 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 1.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.5 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 2.5 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 6.5 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.0 | 0.3 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.3 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 13.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.8 | 5.9 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.7 | 2.0 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.6 | 11.5 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.5 | 5.7 | GO:0042612 | MHC protein complex(GO:0042611) MHC class I protein complex(GO:0042612) |
0.5 | 3.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 3.3 | GO:0043196 | varicosity(GO:0043196) |
0.4 | 2.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.2 | 0.7 | GO:0071746 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.2 | 1.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 1.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.2 | 2.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.5 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.1 | 0.5 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 4.7 | GO:0097542 | ciliary tip(GO:0097542) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 4.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.0 | 0.1 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.0 | 0.9 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 13.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.9 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.7 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 1.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.2 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 1.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 1.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 9.5 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.0 | 2.4 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 1.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.7 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.6 | 4.7 | GO:0034146 | B-1 B cell homeostasis(GO:0001922) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
1.4 | 1.4 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
1.3 | 3.9 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
1.3 | 3.8 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
1.2 | 10.7 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
1.2 | 5.9 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.8 | 3.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.8 | 3.8 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.8 | 2.3 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.8 | 6.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.7 | 2.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.7 | 4.9 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 3.3 | GO:0033590 | response to cobalamin(GO:0033590) |
0.7 | 2.0 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.6 | 3.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.6 | 2.4 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.6 | 5.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.6 | 5.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.6 | 2.8 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
0.5 | 2.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.4 | 6.7 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
0.4 | 2.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.4 | 3.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.4 | 1.2 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.4 | 1.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.4 | 1.1 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.4 | 7.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.4 | 1.5 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) negative regulation of macrophage apoptotic process(GO:2000110) |
0.3 | 2.6 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.3 | 3.6 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 2.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.3 | 4.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.2 | 1.2 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.2 | 0.5 | GO:0045359 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.2 | 1.4 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.2 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.2 | 0.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 1.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 0.5 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 0.9 | GO:0007296 | vitellogenesis(GO:0007296) |
0.2 | 1.4 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 1.6 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 0.4 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.3 | GO:0060584 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 0.4 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.1 | 14.0 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.7 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 2.7 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.1 | 0.4 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.5 | GO:0050821 | protein stabilization(GO:0050821) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 2.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.7 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.3 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.1 | 0.1 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 1.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.5 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 0.2 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.3 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.9 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.0 | 0.2 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 2.7 | GO:0060113 | inner ear receptor cell differentiation(GO:0060113) |
0.0 | 3.7 | GO:0035690 | cellular response to drug(GO:0035690) |
0.0 | 0.4 | GO:0045842 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.0 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 2.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.7 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.1 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.0 | 0.9 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:1904996 | PML body organization(GO:0030578) positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.0 | 0.8 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
0.0 | 0.7 | GO:0003094 | glomerular filtration(GO:0003094) |
0.0 | 0.6 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 1.5 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.1 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.0 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.0 | 0.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.4 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.2 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 1.0 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.0 | 3.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 1.0 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.0 | 0.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.5 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.3 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.1 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 5.0 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 2.7 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 6.0 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 1.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.2 | 2.4 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.2 | 0.8 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.2 | 1.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.2 | 1.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.2 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.7 | GO:0042825 | TAP complex(GO:0042825) |
0.1 | 1.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 5.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 1.0 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.4 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.3 | GO:0033643 | host cell part(GO:0033643) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.2 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 2.9 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 0.6 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 1.0 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 1.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 1.1 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.0 | 1.2 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.9 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.2 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.5 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.0 | 0.5 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.0 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
0.0 | 0.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.1 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.1 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.1 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.5 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 26.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.8 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.2 | 1.6 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 3.4 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 3.0 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 6.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 6.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.1 | 3.3 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 2.6 | PID EPO PATHWAY | EPO signaling pathway |
0.1 | 3.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.7 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 1.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.2 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 2.7 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.1 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 0.3 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 4.3 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
1.1 | 6.7 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.8 | 2.5 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.8 | 2.5 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.6 | 5.1 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.5 | 1.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.5 | 1.6 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.5 | 0.5 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.5 | 1.9 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.4 | 2.7 | GO:0033590 | response to cobalamin(GO:0033590) |
0.4 | 2.9 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.4 | 1.4 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.4 | 1.1 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.3 | 3.5 | GO:0070424 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) |
0.3 | 1.6 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
0.3 | 1.2 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.3 | 0.8 | GO:0046136 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.2 | 2.4 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 2.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.2 | 1.3 | GO:2000669 | positive regulation of pinocytosis(GO:0048549) negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.2 | 0.8 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.2 | 0.6 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.2 | 0.8 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
0.2 | 0.5 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.2 | 0.7 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.2 | 5.0 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.2 | 0.7 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.2 | 1.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 0.8 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.4 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 2.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.4 | GO:0072554 | arterial endothelial cell fate commitment(GO:0060844) blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.1 | 0.4 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.4 | GO:0070431 | nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.4 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.1 | 0.6 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.1 | 0.5 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 2.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.1 | 0.4 | GO:0048861 | oncostatin-M-mediated signaling pathway(GO:0038165) leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.3 | GO:2000777 | positive regulation of oocyte maturation(GO:1900195) negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.1 | 0.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.9 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.4 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.1 | 0.3 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.1 | 0.6 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.1 | 0.3 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.1 | 0.3 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
0.1 | 0.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.1 | 0.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.5 | GO:0016559 | peroxisome fission(GO:0016559) |
0.1 | 0.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
0.1 | 0.5 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.0 | 1.0 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.0 | 0.3 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.0 | 0.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.0 | 1.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.0 | 0.1 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 1.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.3 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.0 | 0.9 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.1 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.0 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.0 | 0.4 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.0 | 0.4 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.0 | 0.6 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.0 | 0.2 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.0 | 1.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:1900535 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 3.0 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.0 | 1.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.1 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.0 | 0.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.2 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.0 | 1.6 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.4 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.2 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.3 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.0 | 0.3 | GO:0048820 | hair follicle maturation(GO:0048820) |
0.0 | 0.3 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.5 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.2 | GO:0002829 | negative regulation of type 2 immune response(GO:0002829) |
0.0 | 0.0 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 1.0 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
0.0 | 0.3 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.0 | 0.1 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.0 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.0 | 2.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.4 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.2 | 6.0 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 3.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.2 | 7.1 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 0.8 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.1 | 1.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 1.1 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 0.9 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 1.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 2.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 1.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 2.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.0 | 0.2 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 1.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 0.5 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 9.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 5.0 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.7 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 4.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 2.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 3.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 2.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 1.6 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.3 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 1.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.4 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 6.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.3 | 3.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.3 | 1.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.7 | GO:0004781 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.2 | 1.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 1.1 | GO:0016015 | morphogen activity(GO:0016015) |
0.2 | 1.6 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 2.9 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.4 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
0.1 | 0.3 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.4 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.1 | 3.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) oncostatin-M receptor activity(GO:0004924) interleukin-6 binding(GO:0019981) |
0.1 | 1.1 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 0.7 | GO:0046979 | TAP2 binding(GO:0046979) |
0.1 | 1.6 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.1 | 2.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.4 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
0.1 | 1.0 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 1.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.1 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 0.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 1.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 3.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.3 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.2 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 0.6 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 0.5 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.5 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.0 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.4 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 1.1 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 1.3 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 1.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 1.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.0 | 1.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.3 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 2.9 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.9 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.5 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 1.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 0.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 3.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 2.0 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
0.0 | 0.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.0 | 0.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.9 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.0 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.0 | 0.2 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.3 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |